Fine Organic (FINEORG)
StalwartFairStock Score: 49/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹5,143.8 |
| Market Cap | ₹15,770.88 Cr |
| P/E Ratio | 35.97 |
| ROCE | 26.39% |
| ROE | 16.89% |
| Dividend Yield | 0.21% |
| Profit Growth | 45.94% |
| Debt/Equity | 0.03 |
| Sales Growth | 14.19% |
| Free Cash Flow | ₹-472 Cr |
| Promoter Holding | 75% |
| 52-Week Range | ₹3,856 — ₹5,390.7 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹869.06 |
Strengths
- Near-zero debt (D/E 0.01) with ROCE of 26.39% and ROE of 16.89% shows strong capital efficiency without leverage.
- Promoter holding of 75% ensures strong owner alignment.
- Five-year revenue CAGR of 14.90% indicates a track record of long-term compounding.
- Latest quarter sales of ₹555 Cr and net profit of ₹74 Cr show the business still generates meaningful operating profits.
Concerns
- Profit growth is negative at -10.59%, and the Piotroski Score of 4/9 points to weakening fundamentals.
- Free cash flow is -₹472 Cr, raising serious doubts about earnings quality.
- Valuation is expensive at P/E of 36.89, P/B of 7.48, and PEG of 5.03, leaving no margin of safety.
- Dividend yield is negligible at 0.23%, and sales growth has slowed to 7.34%.
AI Analysis
Let me look at Fine Organic the way I look at any business: can I understand it, does it earn good returns, and is the price sensible? The company operates in specialty chemicals, and the numbers show a business with genuine strengths. It is almost debt-free, with debt-equity of only 0.01. Return on capital employed of 26.39% is excellent, and return on equity of 16.89% is respectable. Promoters holding 75% means my interests are aligned with people who think like owners. A five-year revenue CAGR of 14.90% tells me the business has compounded steadily. But the last twelve months are less comforting. Revenue grew only 7.34%, while profit actually fell 10.59%. The latest quarter's net profit of ₹74 Cr on sales of ₹555 Cr is okay, but free cash flow is minus ₹472 Cr, which worries me more than reported earnings. A company earning profits but burning cash needs explanation. The Piotroski score of 4 out of 9 also suggests financial strain beneath the surface. The bigger problem is price. At ₹4,977.65, the stock trades at 36.89 times earnings and 7.48 times book value. For a business with declining profits and high single-digit sales growth, that is no margin of safety. PEG of 5.03 tells the same story: you are paying a very high multiple for modest growth. Dividend yield of 0.23% offers little comfort while waiting. This is a good-quality, debt-light niche player, but good business and good investment are different things. A stalwart franchise deserves a fair price. Today, the price already discounts perfection, and the recent cash flow and profit trends are far from perfect. I will keep it on my watchlist, not in my wallet.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer